Targeted Radionuclide Tumor Therapy Biological Aspects /
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2008.
|
| Edition: | 1st ed. 2008. |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-4020-8696-0 |
Table of Contents:
- to Radionuclide Therapy
- Therapeutically Used Targeted Antigens in Radioimmunotherapy
- EGFR-Family Expression and Implications for Targeted Radionuclide Therapy
- Targeting Tumours with Radiolabeled Antibodies
- Antibody Fragments Produced by Recombinant and Proteolytic Methods
- Novel Alternative Scaffolds and Their Potential Use for Tumor Targeted Radionuclide Therapy
- Peptides for Radionuclide Therapy
- Choice of Radionuclides and Radiolabelling Techniques
- High-LET-Emitting Radionuclides for Cancer Therapy
- Targeted High-LET Therapy of Bone Metastases
- The Auger Effect in Molecular Targeting Therapy
- Radiation Induced Cell Deaths
- Radiation Induced DNA-Damage/Repair and Associated Signaling Pathways
- Radiation Induced DNA Damage Checkpoints
- Cancer Stem Cells and Radiation
- Effects of Low Dose-Rate Radiation on Cellular Survival
- Bystander Effects and Radionuclide Therapy
- Enhancing the Efficiency of Targeted Radionuclide Therapy
- Low Dose Hyper-Radiosensitivity: A Historical Perspective
- Clinical Radionuclide Therapy
- Developmental Trends in Targeted Radionuclide Therapy: Biological Aspects.